COMP <GO>
LMAT vs XRAY // FORWARD P/E MULTIPLE
LeMaitre Vascular Inc. (NASDAQ) VS. DENTSPLY SIRONA Inc. (NASDAQ) • 15-METRIC TALLY: LMAT 8
— XRAY 3
■ METRIC PARITY
LAST: $80.94 (-5.08%) • MKT CAP: $1.95B
forward-pe
28.4x
LAST: $9.53 (-0.83%) • MKT CAP: $1.92B
forward-pe
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LMAT VS. XRAY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LMAT | XRAY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 71.50% | 50.00% | +21.50 | LMAT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.70% | -11.00% | +25.70 | LMAT | /roic <GO> |
| EV/EBITDA & P/E Valuation | 28.3x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.17% | 12.27% | -8.10 | XRAY | /fcf-yield <GO> |
| Operating Margin | 27.20% | -11.50% | +38.70 | LMAT | /operating-margins <GO> |
| Net Profit Margin | 23.10% | -16.20% | +39.30 | LMAT | /net-margins <GO> |
| Revenue Growth (YoY) | 13.50% | -3.00% | +16.50 | LMAT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.93% | 6.68% | -5.75 | XRAY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.30 | 0.45 | +6.85 | LMAT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 6/9 | +2.00 | LMAT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.2 | 56.5 | -0.30 | XRAY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 28.4x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.95B | $1.92B | $34.3M | LMAT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LMAT REV | XRAY REV | LMAT GROSS % | XRAY GROSS % | LMAT FCF | XRAY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $249.6M | $3.68B | 71.5% | 50.0% | $81.3M | $235.0M |
| FY 2024 | $219.9M | $3.79B | 68.6% | 51.6% | $44.1M | $461.0M |
| FY 2023 | $193.5M | $3.96B | — | — | $36.8M | $377.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LMAT // BETA —
XRAY // BETA —